Nanobiotechnology and Nanomedicine Companies

A genomics company that has developed the world's first light-powered microtransponders and nanotransponders for performing nucleic acid-based assays.

Develops and sells patented high performance, injection-molded nanospray devices for mass spectrometry applications in drug discovery, clinical diagnostics and homeland security.

Promega's products are used in life science research, particularly in genomics, proteomics, and cellular analysis to support molecular diagnostics and human identification.

A provider of innovative technologies and products for preanalytical sample preparation and molecular diagnostics solutions such as the HiLight Array System that uses Resonance Light Scattering (RLS), a technology based on the optical light scattering properties of nano-sized metal colloid particles.

Quanterix Corporation is developing a novel platform for single molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research.

A nanotechnology company devoted to developing, and commercializing the Personal Laboratory System™, a lab-on-a-chip analysis platform for droplet-based ('digital') microfluidics.

Randox Food Diagnostics is a division of Randox Laboratories who have 30 years experience in the diagnostic market and a devoted research and development team. Randox Food Diagnostics is a dedicated company responsible for the distribution of Randox drug residue kits, wine testing kits and analysers worldwide. Randox Food Diagnostics incorporate several market related products dedicated to the food, wine and beverage industries. Randox uses in house developed antibodies and conjugates for a wide range of their screening products including the patented Biochip Array Technology (multiplex screening platform).

Silicon Biosystems has developed a set of proprietary solutions called lab-on-a-chip technologies, targeted at miniaturized cell-biology testing. Silicon Biosystems exploits the microelectronics potential in order to produce miniaturized cellular biology laboratories.

The company has developed its proprietary nano-Pore Optical lnterferometry (nPOI) platform for biomolecular interaction analysis.

The company develops nanoparticle-based contrast agents for diagnostic imaging with a focus on magnetic resonance imaging (MRI).

Sphere is commercializing picodroplet technology from Cambridge University that can perform thousands of simultaneous reactions on single cells and molecules contained within aqueous droplets, fractions of a millimeter in size. This platform enables diverse applications including: miniaturized profiling of drug candidates, generation of new biocatalysts and identification of novel algal strains.

The company develops biosensor technology that incorporates a proprietary nanostructured optical grating,

T2 Biosystems is creating a new generation of lab-quality diagnostic tools. Its technology is based on superparamagnetic nanoparticles. NanoDx particles have a superparamagnetic metal core surrounded by a polymer layer decorated by multiple analyte-specific binding agents. This nanoparticle platform can be used with a variety of binding agents such as antibodies, nucleic acids and small molecules.

uFluidix develops and manufacturing Point of Care Diagnostic devices and cartridges which uses microfluidic and nanotechnology.

The company sells nanowire sensing devices for molecular diagnostics - real-time, continuous flow and label free over 5 logs dynamic range to 10s of fm/mL sensitivity of proteins, nucleic acid and viruses. Virus LOD is single viruses.

Offers new culture and exposure systems for in vitro studies of gases or complex mixtures. The VITROCELL modules offer new possibilities for the characterization of the effects of airborne substances such as gases nanoparticles and complex mixtures.

The company develops Surface Plasmon Resonance (SPR) biosensors to analyze macromolecular interactions in real-time and label-free.